The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The Paradox of the Low-Renin State in Diabetic Nephropathy
Abstract
Although diabetic nephropathy is often a low renin state, the renin system appears to be implicated in its pathogenesis. In this study, it was hypothesized that the low plasma renin activity (PRA) is misleading, masking and perhaps reflecting an activated intrarenal renin system. PRA and renal vascular responses (inulin and para-aminohippurate clearance) to graded doses of an angiotensin II (AngII) antagonist, irbesartan, were assessed in eight healthy volunteers and 12 patients with type 2 diabetes mellitus and nephropathy on a 10 mmol Na intake, to activate the renin system. Basal PRA was suppressed in type 2 diabetes mellitus compared with the healthy subjects (0.58 +/- 0.14 versus 1.58 +/- 0.28 ng/L per s, mean +/- SEM; P < 0.01). Despite the low PRA, renal perfusion rose more in response to irbesartan in type 2 diabetes mellitus (714 +/- 83 to 931 +/- 116 ml/min; P = 0.002) than normal (624 +/- 29 to 772 +/- 49 ml/min; P = 0.008). The youngest patients were hyperfiltrating and showed the largest rise in renal plasma flow in response to irbesartan, whereas renal plasma flow rose less and GFR fell in patients with low basal GFR. PRA rose in response to irbesartan more gradually in the patients with type 2 diabetes mellitus, but ultimately matched the normal response. To account for the apparent paradox of a heightened renal hemodynamic response to an AngII antagonist in the face of a low PRA in type 2 diabetes mellitus, and the rise in PRA following the AngII antagonist, it is proposed that there is increased intrarenal AngII production in type 2 diabetes mellitus. This increase could account for suppressed circulating renin, the exaggerated renal vasodilator response to irbesartan, and the therapeutic effectiveness of interrupting the renin system in diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Polonsky, K. S., Sturis, J., & Bell, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341207 · Cited by 595
Nelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 477
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
Parving, H.-H., Gall, M.-A., Skøtt, P., Jørgensen, H. E., Løkkegaard, H., Jørgensen, F., Nielsen, B., & Larsen, S. (1992) · Kidney International · doi:10.1038/ki.1992.118 · Cited by 440
Cross-talk between the insulin and angiotensin signaling systems.
Velloso, L. A., Folli, F., Sun, X. J., White, M. F., Saad, M. J., & Kahn, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12490 · Cited by 403
Ravid, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440030080010 · Cited by 314
Anderson, S., Jung, F. F., & Ingelfinger, J. R. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.4.f477 · Cited by 307
Heterogeneous nature of renal lesions in type II diabetes.
Gambara, V, Mecca, G., Remuzzi, G., & Bertani, T. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v381458 · Cited by 257
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue.
Frederich, R. C., Kahn, B. B., Peach, M. J., & Flier, J. S. (1992) · Hypertension · doi:10.1161/01.hyp.19.4.339 · Cited by 244
Bloem, L. J., Manatunga, A. K., Tewksbury, D. A., & Pratt, J. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117803 · Cited by 244
Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz, H. E., Wiegmann, T. B., Cnaan, A., Shahinfar, S., Sica, D. A., Broadstone, V. L., Schwartz, S. L., Mengel, M. C., Segal, R., & Versaggi, J. A. (1994) · PubMed · Cited by 219
Role of EDRF (nitric oxide) in diabetic renal hyperfiltration
Bank, N., & Aynedjian, H. S. (1993) · Kidney International · doi:10.1038/ki.1993.183 · Cited by 211
Plasma Angiotensinogen Concentrations in Obese Patients
Umemura, S. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00053-8 · Cited by 170
Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat
Ballermann, B. J., Skorecki, K. L., & Brenner, B. M. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.247.1.f110 · Cited by 161
The paradox of the renin-angiotensin system in chronic renal disease
Rosenberg, M. E., Smith, L. J., Correa‐Rotter, R., & Hostetter, T. H. (1994) · Kidney International · doi:10.1038/ki.1994.52 · Cited by 157
Hopkins, P. N., Lifton, R. P., Hollenberg, N. K., Jeunemaı̂tre, X., Hallouin, M., Skuppin, J., Williams, C. S., Dluhy, R. G., Lalouel, J.-M., Williams, R. R., et al. (1996) · Journal of Hypertension · doi:10.1097/00004872-199602000-00008 · Cited by 156
Self-citationSlataper, R., Vicknair, N., Sadler, R., & Bakris, G. L. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410080037006 · Cited by 139
Hyporeninemia and Hypoaldosteronism in Diabetes Mellitus
Pérez, G. O. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630190020008 · Cited by 106
Jeffers, B. W., Estacio, R. O., Raynolds, M. V., & Schrier, R. W. (1997) · Kidney International · doi:10.1038/ki.1997.355 · Cited by 104
Miller, J., Floras, J. S., Zinman, B., Skorecki, K. L., & Logan, A. G. (1996) · Clinical Science · doi:10.1042/cs0900189 · Cited by 100
Non-modulation as an intermediate phenotype in essential hypertension.
Williams, G. H., Dluhy, R. G., Lifton, R. P., Moore, T. J., Gleason, R. E., Williams, R. R., Hunt, S. C., Hopkins, P. N., & Hollenberg, N. K. (1992) · Hypertension · doi:10.1161/01.hyp.20.6.788 · Cited by 97
Self-citationRenal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats
Vallon, V., Wead, L. M., & Blantz, R. C. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5101761 · Cited by 86
Wílkes, B. M. (1987) · Endocrinology · doi:10.1210/endo-120-4-1291 · Cited by 72
How should renal hemodynamic data be indexed in obesity?
Schmieder, R. E., Beil, A., Weihprecht, H., & Messerli, F. H. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v591709 · Cited by 69
DE'OLIVEIRA, J. M. F., Price, D. A., Fisher, N. D. L., Allan, D. R., McKnight, J. A., Williams, G. H., & Hollenberg, N. K. (1997) · Kidney International · doi:10.1038/ki.1997.394 · Cited by 68
Self-citationHemodynamic Alterations in Hypertensive Obese Rabbits
Carroll, J. F., Huang, M., Hester, R. L., Cockrell H., K., & Mizelle, L. (1995) · Hypertension · doi:10.1161/01.hyp.26.3.465 · Cited by 67
Shoback, D., Williams, G. H., Hollenberg, N. K., DAVIES, R. O., Moore, T. J., & Dluhy, R. G. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-4-764 · Cited by 67
Self-citationObesity, Salt Intake, and Renal Perfusion in Healthy Humans
Porter, L. E., & Hollenberg, N. K. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.144 · Cited by 63
Self-citationGlomerular hypertension: cause and consequence of renal injury.
Neuringer, J. R., & Brenner, B. M. (1992) · PubMed · Cited by 61
Renal Hemodynamics in Recent-Onset Type II Diabetes
Nowack, R., Raum, E., Blum, W. F., & Ritz, E. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70296-2 · Cited by 56
Lush, D. J., King, J. A., & Fray, J. C. (1993) · Kidney International · doi:10.1038/ki.1993.140 · Cited by 56
Renal Hemodynamic Response to an Angiotensin II Antagonist, Eprosartan, in Healthy Men
Price, D. A., DE'OLIVEIRA, J. M. F., Fisher, N. D. L., & Hollenberg, N. K. (1997) · Hypertension · doi:10.1161/01.hyp.30.2.240 · Cited by 56
Self-citationEffects of preglomerular and postglomerular vascular resistance alterations on filtration fraction.
Carmines, P. K., Perry, M. D., Hazelrig, J. B., & Navar, L. G. (1987) · PubMed · Cited by 55
Genetic Variation on Chromosome 1 Associated With Variation in Body Fat Distribution in Men
Hegele, R. A., Brunt, J., & Connelly, P. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1089 · Cited by 54
The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
Kalinyak, J. E., Sechi, L. A., Griffin, C. A., Don, B. R., Tavangar, K., Kraemer, F. B., Hoffman, A. R., & Schambelan, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v461337 · Cited by 54
Cardiovascular regulation in obesity-induced hypertension.
Rocchini, A. P. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i56 · Cited by 46
Tamura, K., Tanimoto, K., Ishii, M., Murakami, K., & Fukamizu, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82433-4 · Cited by 37
Biphasic Alteration of Renin-Angiotensin-Aldosterone System in Streptozotocin-Diabetic Rats
Kikkawa, R., Kitamura, E., Fujiwara, Y., Haneda, M., & Shigeta, Y. (1986) · Kidney & Blood Pressure Research · doi:10.1159/000173083 · Cited by 37
The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
Björck, S. (1990) · PubMed · Cited by 36
EFFECTS OF INSULIN AND GLUCAGON ON PRODUCTION OF RENIN SUBSTRATE BY THE ISOLATED RAT LIVER
Murakami, E., Hiwada, K., & Kokubu, T. (1980) · Journal of Endocrinology · doi:10.1677/joe.0.0850151 · Cited by 33
Renin regulation in type II diabetes mellitus: influence of dietary sodium.
Trujillo, A., Eggena, P., Barrett, J., & Tuck, M. L. (1989) · Hypertension · doi:10.1161/01.hyp.13.3.200 · Cited by 32
Pharmacologic manipulation of glomerular functionter
ter Wee, P. M., & Donker, A. J. M. (1994) · Kidney International · doi:10.1038/ki.1994.54 · Cited by 22
Cited by
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Heerspink, H. J. L., Perkins, B. A., Fitchett, D. H., Husain, M., & Cherney, D. Z. I. (2016) · Circulation · doi:10.1161/circulationaha.116.021887 · Cited by 1,376
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A. W., Kong, J., Quigg, R. J., & Li, Y. C. (2008) · Kidney International · doi:10.1038/sj.ki.5002572 · Cited by 305
Metadata
- Authors
- PRICE, D. A., PORTER, L. E., GORDON, M., FISHER, N. D. L., DE'OLIVEIRA, J. M. F., LAFFEL, L. M. B., PASSAN, D. R., WILLIAMS, G. H., & HOLLENBERG, N. K.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1999-11
- Volume
- 10
- Issue
- 11
- Pages
- 2382-2391
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2125524254
- Cited by
- 272
- References
- 42
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.